0 191

Cited 0 times in

Phase II study of gemcitabine with oxaliplatin (GEMOX) in heavily treated patients with advanced hepatocellular carcinoma after failure of sorafenib treatment (PEACH)

DC Field Value Language
dc.contributor.author김한상-
dc.contributor.author이충근-
dc.contributor.author최혜진-
dc.date.accessioned2023-06-02T01:05:42Z-
dc.date.available2023-06-02T01:05:42Z-
dc.date.issued2022-02-
dc.identifier.issn0732-183X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194649-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherAmerican Society of Clinical Oncology-
dc.relation.isPartOfJOURNAL OF CLINICAL ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titlePhase II study of gemcitabine with oxaliplatin (GEMOX) in heavily treated patients with advanced hepatocellular carcinoma after failure of sorafenib treatment (PEACH)-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorChoong-kun Lee-
dc.contributor.googleauthorHan Sang Kim-
dc.contributor.googleauthorHye Jin Choi-
dc.identifier.doi10.1200/JCO.2022.40.4_suppl.456-
dc.contributor.localIdA01098-
dc.contributor.localIdA03259-
dc.contributor.localIdA04219-
dc.relation.journalcodeJ01331-
dc.identifier.eissn1527-7755-
dc.identifier.urlhttps://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.456-
dc.contributor.alternativeNameKim, Han Sang-
dc.contributor.affiliatedAuthor김한상-
dc.contributor.affiliatedAuthor이충근-
dc.contributor.affiliatedAuthor최혜진-
dc.citation.volume40-
dc.citation.number4-
dc.citation.startPage456-
dc.identifier.bibliographicCitationJOURNAL OF CLINICAL ONCOLOGY, Vol.40(4) : 456, 2022-02-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.